Quest Diagnostics' (DGX) Hold Rating Reaffirmed at KeyBanc

Quest Diagnostics' (DGX) Hold Rating Reaffirmed at KeyBanc


's stock had its "hold" rating reiterated by research analysts at KeyBanc in a note issued to investors on Sunday. Other equities analysts also recently issued research reports about the stock.



from Biotech News